About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 1/2NCT00188578

Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)

Standard treatment for gynecological cancer is radiation therapy in two phases; whole pelvic radiation and then an internal radiation boost, also called a brachytherapy boost, to treat any remaining t...

Lead sponsor: University Health Network, Toronto•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Health Network, Toronto

Collaborators

Princess Margaret Hospital, Canada

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Biopsy-proven carcinoma of the cervix, uterus or vagina; FIGO stage T1B-4A, NO/1, MO, treated with definitive radiotherapy with or without chemotherapy, or Biopsy-proven pelvic recurrence of carcinoma of the uterus previously untreated or biopsy-proven vaginal carcinoma treated radically with radiotherapy but unsuitable for brachytherapy boost.
•Patients not suitable for intracavitary brachytherapy.
•ECOG performance status of 0, 1, or 2
•Age ≥ 18 years
•Ability to give informed consent.

Related studies

RECRUITINGPhase 2

Agnostic Therapy in Rare Solid Tumors

NCT06638931 · Urachal Cancer, Parathyroid Carcinoma, and more

Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms

NCT03624712 · Uterine Neoplasms

Active Not RecruitingPhase 1

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

NCT07038369 · Advanced Solid Tumors, Breast Cancer, and more

Active Not RecruitingPhase 2

Cervix: Hypoxia, Interstitial Fluid Pressure and GSH Levels

NCT00188539 · Cervix Neoplasms

Active Not RecruitingPhase 2

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

NCT04579380 · Uterine Neoplasms, Uterine Cervical Neoplasms, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 9, 2016Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1/PHASE2

Enrollment12

Start dateJun 2003

Last updatedFeb 9, 2016

Condition

Cervix Neoplasms Uterine Neoplasms Vaginal Neoplasms

Locations shown

Princess Margaret Hospital

Toronto, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 9, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions